• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性粒单核细胞白血病

Chronic myelomonocytic leukemia.

作者信息

Storniolo A M, Moloney W C, Rosenthal D S, Cox C, Bennett J M

机构信息

Department of Medicine, University of California, San Diego, LaJolla.

出版信息

Leukemia. 1990 Nov;4(11):766-70.

PMID:2232890
Abstract

Thirty adult patients with CMML were evaluated to determine prognostic factors that might have an impact on conversion to acute leukemia and survival. Neither leukocyte count nor monocyte count correlated with survival. The median survival for all 30 cases was 41 months. Patients with less than 5% marrow blasts had a median survival of 60 months but those with 5-20% blasts had only a 9-month median survival.

摘要

对30例成年慢性粒-单核细胞白血病(CMML)患者进行评估,以确定可能影响向急性白血病转化及生存的预后因素。白细胞计数和单核细胞计数均与生存无相关性。30例患者的中位生存期为41个月。骨髓原始细胞少于5%的患者中位生存期为60个月,而原始细胞为5%-20%的患者中位生存期仅为9个月。

相似文献

1
Chronic myelomonocytic leukemia.慢性粒单核细胞白血病
Leukemia. 1990 Nov;4(11):766-70.
2
Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.中国 41 例慢性粒单核细胞白血病患者的临床特征和预后分析。
Leuk Res. 2010 Apr;34(4):458-62. doi: 10.1016/j.leukres.2009.07.011. Epub 2009 Jul 24.
3
Chronic myelomonocytic leukemia (CMML)--characterization of clinical features and prognosis.
Nihon Ketsueki Gakkai Zasshi. 1988 Dec;51(8):1441-7.
4
Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.由慢性髓单核细胞白血病继发的急性髓系白血病的临床病理分析。
Mod Pathol. 2013 Jun;26(6):751-61. doi: 10.1038/modpathol.2012.218. Epub 2013 Jan 11.
5
Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.骨髓增生异常型和骨髓增殖型慢性粒单核细胞白血病的预后因素:来自单一机构的83例患者的回顾性分析
Haematologica. 2004 Jul;89(7):866-8.
6
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.骨髓纤维化与慢性粒单核细胞白血病不良生存结局相关。
Ann Hematol. 2018 Jul;97(7):1183-1191. doi: 10.1007/s00277-018-3289-6. Epub 2018 Mar 20.
7
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine.阿扎胞苷治疗慢性粒单核细胞白血病患者的反应和生存的预测因素。
Leuk Res. 2013 Jun;37(6):609-13. doi: 10.1016/j.leukres.2013.01.004. Epub 2013 Feb 12.
8
[Chronic myelomonocytic leukemia].[慢性粒单核细胞白血病]
Ter Arkh. 1988;60(11):120-3.
9
[Clinical study on heterogeneity of chronic myelomonocytic leukemia].[慢性粒单核细胞白血病异质性的临床研究]
Rinsho Ketsueki. 1990 Dec;31(12):1906-13.
10
Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.骨髓增生异常综合征患者骨髓单核细胞结节的临床意义:21例回顾性分析
Am J Hematol. 2005 Aug;79(4):329-31. doi: 10.1002/ajh.20410.

引用本文的文献

1
Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia.慢性粒单核细胞白血病患者高球蛋白血症的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):21-26. doi: 10.1007/s10354-022-00983-6. Epub 2022 Nov 29.
2
Significance of C-reactive protein in patients with chronic myelomonocytic leukemia.C 反应蛋白在慢性粒单核细胞白血病患者中的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):15-20. doi: 10.1007/s10354-022-00981-8. Epub 2022 Nov 28.
3
Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia.
慢性粒单核细胞白血病患者心血管合并症的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):27-33. doi: 10.1007/s10354-022-00982-7. Epub 2022 Nov 21.
4
Significance of reduced renal function in patients with chronic myelomonocytic leukemia.慢性粒单核细胞白血病患者肾功能降低的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):3-8. doi: 10.1007/s10354-022-00977-4. Epub 2022 Oct 25.
5
Treatment options and survival in real life during the past three decades in patients with chronic myelomonocytic leukemia.在过去三十年中,慢性髓单核细胞白血病患者的真实生活中的治疗选择和生存情况。
Wien Med Wochenschr. 2023 Feb;173(1-2):34-40. doi: 10.1007/s10354-022-00976-5. Epub 2022 Oct 25.
6
Significance of abnormal blood coagulation in patients with chronic myelomonocytic leukemia.慢性粒单核细胞白血病患者血液凝固异常的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):9-14. doi: 10.1007/s10354-022-00969-4. Epub 2022 Oct 7.
7
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.ABNL-MARRO 001 研究:一项在 MDS/MPN 重叠综合征中随机分配活性髓系靶向化合物组合的 1-2 期研究。
BMC Cancer. 2022 Sep 24;22(1):1013. doi: 10.1186/s12885-022-10073-w.
8
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches.慢性粒单核细胞白血病的分子发病机制及治疗方法的潜在分子靶点
Front Oncol. 2021 Sep 30;11:751668. doi: 10.3389/fonc.2021.751668. eCollection 2021.
9
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.慢性粒单核细胞白血病中白血病起始干细胞的表型特征。
Leukemia. 2021 Nov;35(11):3176-3187. doi: 10.1038/s41375-021-01227-z. Epub 2021 Mar 30.
10
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.经典慢性髓单核细胞白血病(CMML)、CMML 变异型和 CMML 前期疾病的拟议诊断标准。
Haematologica. 2019 Oct;104(10):1935-1949. doi: 10.3324/haematol.2019.222059. Epub 2019 May 2.